Inogen (INGN) EBITDA Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 1,711.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,711.00 |
| Dec 31, 2025 | 5,601.00 |
| Sep 30, 2025 | 452.00 |
| Jun 30, 2025 | 370.00 |
| Mar 31, 2025 | 1,174.00 |
| Dec 31, 2024 | 1,398.00 |
| Sep 30, 2024 | -2,009.00 |
| Jun 30, 2024 | -1,273.00 |
| Mar 31, 2024 | -1,965.00 |
| Dec 31, 2023 | -2,578.00 |
| Sep 30, 2023 | -5,307.00 |
| Jun 30, 2023 | -1,543.00 |
| Mar 31, 2023 | -2,657.00 |
| Dec 31, 2022 | -6,189.00 |
| Sep 30, 2022 | -1,642.00 |
| Jun 30, 2022 | -1,436.00 |
| Mar 31, 2022 | -2,407.00 |
| Dec 31, 2021 | -4,181.00 |
| Sep 30, 2021 | -147.00 |
| Jun 30, 2021 | -969.00 |
| Mar 31, 2021 | -1,399.00 |
| Dec 31, 2020 | -599.00 |
| Sep 30, 2020 | -1,314.00 |
| Jun 30, 2020 | -914.00 |
| Mar 31, 2020 | -1,271.00 |
| Dec 31, 2019 | -1,243.00 |
| Sep 30, 2019 | -262.00 |
| Jun 30, 2019 | -409.00 |
| Mar 31, 2019 | 35.00 |
| Dec 31, 2018 | 219.00 |
| Sep 30, 2018 | 1,032.00 |
| Jun 30, 2018 | 790.00 |
| Mar 31, 2018 | 897.00 |
| Dec 31, 2017 | -576.00 |
| Sep 30, 2017 | -116.00 |
| Jun 30, 2017 | -13.00 |
| Mar 31, 2017 | 486.00 |
| Dec 31, 2016 | 747.00 |
| Sep 30, 2016 | 517.00 |
| Jun 30, 2016 | 208.00 |
| Mar 31, 2016 | 166.00 |